Navigation Links
VWR to Hold First Quarter 2012 Financial Results Conference Call
Date:5/7/2012

RADNOR, Pa., May 7, 2012 /PRNewswire/ -- VWR Funding, Inc., the parent company of VWR International, LLC, a leading global laboratory supply and distribution company, will hold a conference call on Thursday, May 10, 2012, to discuss its first quarter 2012 financial results. Who:John M. Ballbach, Chairman, President and CEOGregory L. Cowan, Senior Vice President and CFOWhen:Thursday, May 10, 20129:00 AM Eastern Time (ET)How: 

 

 

Interested parties may participate by dialing (760) 298-5093 or toll free at (877) 845-1003. A replay of the call will be available on Thursday, May 10, 2012 at 12:00 PM ET through Thursday, May 24, 2012 at midnight, by dialing (404) 537-3406 or toll free at (800) 585-8367, pass code for both replay numbers will be 76187966.Information: 

 VWR Funding's Quarterly Report on Form 10-Q for the quarter ended March 31, 2012, will be filed on or before Thursday, May 10, 2012, with the Securities and Exchange Commission.About VWR International, LLC VWR International, LLC, headquartered in Radnor, Pennsylvania, is a global laboratory supply and distribution company with worldwide sales in excess of $4.1 billion in 2011. VWR enables the advancement of the world's most critical research through the distribution of a highly diversified product line to most of the world's top pharmaceutical and biotech companies, as well as industrial, educational and governmental organizations. With 150 years of industry experience, VWR offers a well-established distribution network that reaches thousands of specialized labs and facilities spanning the globe. VWR has over 8,000 associates around the world working to streamline the way researchers across North America, Europe, and Asia stock and maintain their labs. In addition, VWR further supports its customers by providing onsite services, storeroom management, product procurement, supply chain systems integration and technical services.

For more information on VWR, phone 1-800-932-5000, visit www.vwr.com, or write, VWR, Radnor Corporate Center, Building One, Suite 200, 100 Matsonford Road, Radnor, PA 19087.

VWR and design are registered trademarks of VWR International, LLC.


'/>"/>
SOURCE VWR Funding, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. China Pharma Holdings, Inc. to Report First Quarter of Fiscal Year 2012 Financial Results on May 15, 2012
2. PDL BioPharma Announces First Quarter 2012 Financial Results
3. Verenium Corporation To Announce First Quarter 2012 Financial Results
4. Discovery Labs Reports First Quarter 2012 Financial Results
5. Sangamo BioSciences Reports First Quarter 2012 Financial Results
6. MiMedx Group Announces Record First Quarter Results
7. Innophos Holdings, Inc. Reports First Quarter 2012 Results
8. Sangamo BioSciences Announces First Quarter 2012 Conference Call and Webcast
9. Dyadic International To Release First Quarter 2012 Financial Results And Host Conference Call
10. First atomic-scale real-time movies of platinum nanocrystal growth in liquids
11. Cell Therapeutics, Inc. (CTI) Reports First Quarter Financial Results and Milestones
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... (PRWEB) , ... October 12, ... ... today announces publication of a United States multicenter, prospective clinical study that ... disposable, point-of-care diagnostic test capable of identifying clinically significant acute bacterial and ...
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 ... overexpression experiments and avoiding the use of exogenous expression plasmids. The simplicity of ... performing systematic gain-of-function studies. , This complement to loss-of-function studies, such as ...
(Date:10/11/2017)... the Netherlands and LAGUNA HILLS, Calif. ... The Institute of Cancer Research, London ... use MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients ... trial known as MUK nine . The University of ... trial, which is partly funded by Myeloma UK, and ICR ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give ... Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles ...
Breaking Biology Technology:
(Date:4/4/2017)... YORK , April 4, 2017   EyeLock ... today announced that the United States Patent and Trademark ... patent broadly covers the linking of an iris image ... same transaction) and represents the company,s 45 th ... latest patent is very timely given the multi-modal biometric ...
(Date:3/30/2017)... NEW YORK , March 30, 2017 ... by type (physiological and behavioral), by technology (fingerprint, AFIS, ... recognition, voice recognition, and others), by end use industry ... travel and immigration, financial and banking, and others), and ... Europe , Asia Pacific ...
(Date:3/24/2017)... The Controller General of Immigration from Maldives Mr. ... have received the prestigious international IAIR Award for the most innovative ... ... Maldives Immigration ... Algeen (small picture on the right) have received the IAIR award for ...
Breaking Biology News(10 mins):